Medical Device News Magazine

Dave Duff and Jennifer Stanton Join Theranica USA

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...


  • “This is an exciting and important time for both Theranica and the broader migraine treatment market, and we are pleased to welcome Dave and Jen who bring valuable experience as we embark on this next phase of growth,” said Scott Szymanski, president of Theranica USA.

Theranica USA, a fully owned subsidiary of Theranica Bioelectronics today announced the appointment of two senior executives amid growing demand for the company’s prescription migraine treatment device Nerivio®. Dave Duff, formerly of Sunovion Pharmaceuticals, joins Theranica as Head of Marketing and Training, and Jennifer Stanton from pharmaceutical company Zogenix joins as Head of Market Access to lead all reimbursement and access initiatives for Nerivio.

Nerivio, an FDA-authorized prescribed wearable device for the acute treatment of migraine, is worn on the upper arm at migraine onset and utilizes electrical impulses controlled by a smartphone to provide patients with drug-free therapy. Over the past six months, in a limited launch program with select headache clinics in the US, Nerivio was used to treat more than 5,000 patients and provided upwards of 30,000 treatments. Recently, Theranica expanded the availability of Nerivio via telemedicine partnerships with Cove and UpScript to enable rapid consultation with a licensed physician and home delivery of the prescribed device.

“This is an exciting and important time for both Theranica and the broader migraine treatment market, and we are pleased to welcome Dave and Jen who bring valuable experience as we embark on this next phase of growth,” said Scott Szymanski, president of Theranica USA. “From day one our vision was to provide an effective and affordable drug-free treatment option for those living with migraines. With the influx of interest and demand for Nerivio, we are also embarking on a reimbursement initiative that will make our treatment even more accessible to those who need it.”Each Nerivio unit can be used for 12 migraine treatments, after which it can be recycled, and the prescription can be refilled with a new device.

Dave Duff, Head of Marketing and Training, brings over 20 years of CNS marketing and medical communications experience in a variety of roles. Dave most recently was a key contributor to the clinical development and commercialization of a new treatment for Parkinson’s Disease. His vast experience in roles across commercial and medical affairs provides Theranica with a uniquely well-rounded pharmaceutical executive to lead its US marketing effort. “Nerivio can be a game-changer for people living with migraine,” said Duff. “I am excited to lead the marketing efforts on this unique drug-free option that has the potential to help the millions of patients currently dissatisfied with their current acute migraine treatment.”

Jennifer Stanton, Head of Market Access, will lead all reimbursement and access initiatives for Nerivio. Jen brings more than 14 years of pharmaceutical experience, the last six focused on managed care and reimbursement. She most recently helped lead all market access strategic planning for an orphan CNS product launch. “Working in the migraine space has provided me with firsthand understanding of the pervasive effects of migraine, not only to patients’ physical health but to their lifestyle and productivity,” said Stanton. “I’m looking forward to leading Theranica’s access and reimbursement strategy with the goal of providing patients with more affordable access to this innovative migraine treatment.”

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.